The FullSTEP study was a phase 4 , 32-week , randomised , open-label , two-arm , parallel-group , multinational , treat-to-target , non-inferiority trial done at 150 sites across seven countries to assess the effectiveness of a stepwise dosing approach versus a basal-bolus regimen .